HEMOGLOBINOPATHY IN BASRAH GOVERNORATE, CENTER STATISTICS AND NEW REGISTRY CHARACTERISTICS
Downloads
A retrospective study that had been conducted depending on the patients records and center data bases, concentration on the evidence of registering new cases of the disease categories, a total of 8721 patients had been registered most of them was of sickle cell diseases categories (sickle cell anemia, sickle/β+ and sickle/β0) of 5954 (68.26%), thalassemia syndromes (27.71%). 52.11% are males and 47.78% are females with a male: female ratio of 1.09, most of them are of below 18 years old 4741 (54.34%) with an adult group of 3972 (45.54%), one third of them were illiterates the rest were educated of different levels, only 6% reached higher education. 1817 different hemoglobinopathy patients was registered in Basrah during the last five years, 27.6% of them were registered during 2019 alone, 39.8% of them were homozygous sickle cell diseases while heterozygous (sickle/β+, sickle/β0) represented 33.0% of all registered cases, thalassemia syndromes (thalassemia major, thalassemia intermedia and α thalassemia) were only 27.0%. conclusions Basra governorate contain a large cohort of hemoglobinopathies patients on the national level and new case detection and registry is still significantly high for the last five years although premarital screening program did conducted recommendation a more correlational and comparable studies are to be conducted to highlight different variables of the disease-specific characteristics and an evaluation is to be conducted on evidence based way for the outcome of the currently conducted premarital screening program.
Rodigari F, Brugnera G, Colombatti R. Health-related Quality of life in hemoglobinopathies: A systematic review From a global perspective. Front Pediatr. 2022 Aug 25;10:886674. Doi: 10.3389/fped.2022.886674. PMID: 36090573; PMCID: PMC9452907.
Farmakis D, Porter J, Taher A, Domenica Cappellini M,Angastiniotis M, Eleftheriou A. 2021 Thalassaemia International Federation Guidelines for the Management Of Transfusion-dependent Thalassemia. Hemasphere.2022 Jul 29;6(8): e732. Doi:10.1097/HS9.0000000000000732. PMID: 35928543; PMCID: PMC9345633
GBD 2021 Sickle Cell Disease Collaborators. Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021. The Lancet Haematology. 15 June 2023. doi: 10.1016/S2352-3026(23)00118-7
Warghade S, Britto J, Haryan R, Dalvi T, Bendre R, Chheda P, et al.. Prevalence of hemoglobin Variants and hemoglobinopathies using cation-exchange high-performance liquid chromatography In central reference laboratory of india: A report of 65779 cases. J Lab Physicians 2018; 10: 73–79.
Weatherall DJ, Clegg JB.. Inherited haemoglobin disorders: An increasing global health problem. Bull World Health Organ 2001; 79: 704–712.
Frenette PS, Atweh GF. Sickle cell disease: old discoveries, new concepts, and future promise. J Clin Invest 2007;117:850-8.
Weatherall DJ. The Evolving Spectrum of the Epidemiology of Thalassemia. Hematol Oncol Clin North Am. 2018 Apr;32(2):165-175.
Wahed A, Quesada A, Dasgupta A. Hemoglobinopathies and Thalassemias. Academic Press; 2020. https://doi.org/10.1016/B9j78-0-12-814964-5.00004-8.https://doi.org/10.1016/B9j78-0-12-81496.
Lafta RK, Sadiq R, Muhammed ZB. Burden of Thalassemia in Iraq. Public H Open Acc,https://medwinpublishers.com/PHOA/burden-of-thalassemia-in-iraq.pdf. DOI: 10.23880/phoa-16000242
Kountouris et al., 2014 4 Cataldo F. Immigration and changes in the epidemiology of hemoglobin disorders in Italy: an emerging public health burden. Ital J Pediatr. 2012;38:32. https://doi.org/10.1186/1824-7288-38-32/METRICS. https://doi.org/10.1186/1824-7288-38-32/.
Cataldo F. Immigration and changes in the epidemiology of hemoglobin disorders in Italy: an emerging public health burden. Ital J Pediatr. 2012;38:32. https://doi.org/10.1186/1824-7288-38-32/METRICS. https://doi.org/10.1186/1824-7288-38-32/.
GBD 2021 Sickle Cell Disease Collaborators. Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Haematol. 2023 Aug;10(8):e585-e599. Doi: 10.1016/S2352-3026(23)00118-7. Epub 2023 Jun 15. Erratum in: Lancet Haematol. 2023 Aug;10(8):e574. Doi: 10.1016/S2352-3026(23)00215-6. PMID: 37331373; PMCID: PMC10390339
Eman S. Alsaeed, Ghada N. Farhat, Abdullah M. Assiri, Ziad Memish, Elawad M. Ahmed, Mohammad Y. Saeedi, Mishal F. Al-Dossary, Hisham Bashawri (2018) Distribution of hemoglobinopathy disorders in Saudi Arabia based on data from the premarital screening and genetic counseling program, 2011–2015, Journal of Epidemiology and Global Health 7:Suppl. 1, S41–S47, DOI: https://doi.org/10.1016/j.jegh.2017.12.001
Rajab AG, Patton MA, Modell B. Study of hemoglobinopathies in Oman through a national register. Saudi Med J. 2000; 21: 1168-1172.
Rouh AlDeen, N.; Osman, A.A.; Alhabashi, M.J.; Al Khaldi, R.; Alawadi, H.; Alromh, M.K.; Alyafai, E.G.; Akbulut-Jeradi, N. The Prevalence of β-Thalassemia and Other Hemoglobinopathies in Kuwaiti Premarital Screening Program: An 11-Year Experience. J. Pers. Med. 2021, 11, 980. https://doi.org/10.3390/jpm11100980
Kadhim KA, Baldawi KH, Lami FH. Prevalence, Incidence, Trend, and Complications of Thalassemia in Iraq. Hemoglobin. 2017 May;41(3):164-168. Doi: 10.1080/03630269.2017.1354877. Epub 2017 Aug 24. PMID: 28836463.
Al-Hakeim HK, Abdulla AK, Almulla AF, Maes M. Hereditary haematologic disorders in Najaf province-Iraq. Transfus Clin Biol. 2020 Nov;27(4):213-217. Doi: 10.1016/j.tracli.2020.08.008. Epub 2020 Oct 6. PMID: 33036881.
Aziz, S. S., Hamad, B. K., Hamad, H. O., Qader, M. I., Ali, E. N., Muhammed, R. H., & Shekha, M. S. (2022). Estimation of the prevalence of Hemoglobinopathies in Erbil governorate, Kurdistan region of Iraq. Iraqi Journal of Hematology, 11(1), 19
Taj El-Din S et al. Thalassaemia in Iraq. Annals of tropical medicine and parasitology, 1968, 62:147–53.
Baker F, Al-Quasi M. Sickle cell anemia in Iraq: first case report. Journal of the Faculty of Medicine, Baghdad, 1964, 6(5):26–31.
Al-Khaldi YM, Al-Sharif AI, Sadiq AA, et al. Attitudes to Premarital counseling among students of Abha Health Sciences College. Saudi Med J. 2002; 23(8):986-90.
El-Hazmi MA. Pre-marital examination as a method Of prevention from blood genetic disorders. Community views. Saudi Med J. 2006; 27(9): 1291-5.
Tawfik S, Azeem A, Elsayed ET, et al. Promotion of Knowledge and attitude towards premarital care: An Interventional study among medical student in Fayoum University. J Public Health Epidemiol. 2011;3: 121-8..
WHO executive board EB118/5. Prevalence of Haemoglobinopathies. In: 118th Session on Thalassaemia and other haemoglobinopathies Report by the secretariat. Geneva: World Health Organization. 2006:1-8
Resolution WHA59.20. Sickle-cell anaemia . In: Fifty-ninth World Health Assembly. Ge-Neva: World Health Organization; 2006: 26-7.
Khan FZA, Mazhar SB. Current trends of consanguineous marriages and its association with Socio-demographic variables in Pakistan. Int J Reprod Contraception, Obstet Gynecol. 2018;7:1700
Angastiniotis MA, Kyriakidou SM, Hadjiminas M. How tha-
Lassemia was controlled in Cyprus, World health forum, 1986, 7:291–7.
Samavat A, Modell B. Iranian national thalassaemia screening Programme. British medical journal, 2004, 329:1134–7.
Jamison et al., eds. Disease control priorities in developing countries, 2nd ed. Oxford, Oxford University Press, 2006
Hassan MK, Taha JY, Al-Naama LM, Widad NM, Jasim SN. Frequency of haemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in Basra. East Mediterr Health J. 2003;9:45–54.
Farmakis D, Porter J, Taher A, Domenica Cappellini M, Angastiniotis M, Eleftheriou A. 2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia. Hemasphere. 2022 Jul 29;6(8): e732. Doi: 10.1097/HS9.0000000000000732. PMID: 35928543; PMCID: PMC9345633.
Weatherall D.J. The challenge of haemoglobinopathies in poor resource countries. Br. J. Haematol. 2011; 154:736– 744. Doi: 10.1111/j.1365-2141.2011.08742.x.
Alqahtani A, Salih SB, Almoghairi A, Alaklabi A, Alshamrani M, et al. (2023) Prevalence of Hemoglobinopathy in Adult Population at KAMC, Riyadh, Saudi Arabia. J Family Med Prim Care Open Acc 7: 230. DOI: 10.29011/2688-7460.100230.
Warghade S, Britto J, Haryan R, Dalvi T, Bendre R, Chheda P, et al. Prevalence of hemoglobin variants and hemoglobinopathies using cation-exchange high-performance liquid chromatography in central reference laboratory of India: A report of 65779 cases. J Lab Physicians. 2018;10(1):73-79.
Balgir RS. The genetic burden of hemoglobinopathies with special reference to community health in India and the challenges ahead. Indian J Hematol Blood Transfus. 2002;20:2–7.
Shaikh IA, Zubair R, Siddiqui IA, Ahmad AH, Sheikh U. Hematological Parameters and Demographic Distribution of Hemoglobinopathies and Various Hemoglobin Variants. Cureus. 2022;14(12):e33115.
Patel AP, Naik MR, Shah NM, Sharma NP, Parmar PH. Prevalence of common hemoglobinopathies in Gujarat: An analysis of a large population screening programme. Natl J Community Med. 2012;3:112–6.
Rosenfeld LG, Bacal NS, Cuder MA, Silva AG, Machado IE, Pereira CA, et al. Prevalence of hemoglobinopathies in the Brazilian adult population:National Health Survey 2014-2015. Rev Bras Epidemiol. 2019;22:E190007.
Lafta RK, et al. Burden of Thalassemia in Iraq. Public H Open Acc 2023, 7(1): 000242.
Belhoul K.M., Abdulrahman M., Alraei R.F. Hemoglobinopathy carrier prevalence in the United Arab Emirates: First analysis of the Dubai Health Authority premarital screening program results. Hemoglobin. 2013;37:359–368. doi: 10.3109/03630269.2013.791627.
Cousens N.E., Gaff C.L., Metcalfe S.A., Delatycki M.B. Carrier screening for beta thalassaemia: A review of international practice. Eur. J. Hum. Genet. 2010;18:1077–1083. doi: 10.1038/ejhg.2010.90.
Stark Z., Massie J., McClaren B., Loannou L., Cousens N., Lewis S., Metcalfe S., Delatycki M.B. Current practice and attitudes of Australian obstetricians toward population-based carrier screening for inherited conditions. Twin Res. Hum. Genet. 2013;16:601–607. doi: 10.1017/thg.2012.152.
Canatan D., Aydinok Y., Kilinc Y., Karakaş Z., Şaşmaz İ., Apak H., Sarper N. National thalassemia prevention campaign: The talotir project. Turk. J. Haematol. 2013;30:91–92. doi: 10.4274/tjh.2012.0121.
Saffi M., Howard N. Exploring the effectiveness of mandatory premarital screening and genetic counselling programmes for beta-thalassaemia in the Middle East: A scoping review. Public Health Genom. 2015;18:193–203. doi: 10.1159/000430837.
Alswaidi F.M., O’Brien S.J. Premarital screening programmes for haemoglobinopathies, HIV and hepatitis viruses: Review and factors affecting their success. J. Med. Screen. 2009;16:22–28. doi: 10.1258/jms.2008.008029.
Copyright (c) 2024 Batool Falah Hassan, Gadeer Ali Lazim, Montazer Mansour Jassim, Maysaa Basim Obaid, Milad Mohammed Faleeh, Basim Abdulkareem.Alhijaj

This work is licensed under a Creative Commons Attribution 4.0 International License.














